Condition
Waldenstrom Macroglobulinemia (WM) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Waldenstrom Macroglobulinemia (WM) clinical trials that are recruiting, at sites in 8 countries (most in United States (2), France (1), Italy (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 8Countries
All recruiting trials (2)
-
Evaluating NX-5948 for advanced B-cell cancers
This study is testing a new drug called NX-5948 to see if it can safely help adults with tough-to-treat B-cell cancers feel better.
-
Evaluating NX-2127 for adults with advanced B-cell cancers
This study is testing a new treatment called NX-2127 to see if it can help adults with advanced B-cell cancers feel better and fight their disease.
Related topics
Quick answers
How many Waldenstrom Macroglobulinemia (WM) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (2 trials), France (1 trial), Italy (1 trial), Netherlands (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.